125 related articles for article (PubMed ID: 18699941)
1. Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.
Saha S; Mistry V; Siva R; Parker D; May R; Bradding P; Pavord ID; Brightling CE
Allergy; 2008 Sep; 63(9):1239-43. PubMed ID: 18699941
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD.
Saha S; Doe C; Mistry V; Siddiqui S; Parker D; Sleeman M; Cohen ES; Brightling CE
Thorax; 2009 Aug; 64(8):671-6. PubMed ID: 19213775
[TBL] [Abstract][Full Text] [Related]
3. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.
Doe C; Bafadhel M; Siddiqui S; Desai D; Mistry V; Rugman P; McCormick M; Woods J; May R; Sleeman MA; Anderson IK; Brightling CE
Chest; 2010 Nov; 138(5):1140-7. PubMed ID: 20538817
[TBL] [Abstract][Full Text] [Related]
4. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
[TBL] [Abstract][Full Text] [Related]
5. Comparative Study of IL-33 and IL-6 Levels in Different Respiratory Samples in Mild-to-Moderate Asthma and COPD.
Gorska K; Nejman-Gryz P; Paplinska-Goryca M; Korczynski P; Prochorec-Sobieszek M; Krenke R
COPD; 2018 Feb; 15(1):36-45. PubMed ID: 29319364
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.
Kawayama T; Kinoshita T; Matsunaga K; Kobayashi A; Hayamizu T; Johnson M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():295-303. PubMed ID: 26929615
[TBL] [Abstract][Full Text] [Related]
8. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
[TBL] [Abstract][Full Text] [Related]
9. A Sputum Proteomic Signature That Associates with Increased IL-1β Levels and Bacterial Exacerbations of COPD.
Damera G; Pham TH; Zhang J; Ward CK; Newbold P; Ranade K; Sethi S
Lung; 2016 Jun; 194(3):363-9. PubMed ID: 27083436
[TBL] [Abstract][Full Text] [Related]
10. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
[TBL] [Abstract][Full Text] [Related]
11. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
Profita M; Chiappara G; Mirabella F; Di Giorgi R; Chimenti L; Costanzo G; Riccobono L; Bellia V; Bousquet J; Vignola AM
Thorax; 2003 Jul; 58(7):573-9. PubMed ID: 12832668
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine.
Barczyk A; Pierzchala W; Sozañska E
Respir Med; 2003 Jun; 97(6):726-33. PubMed ID: 12814161
[TBL] [Abstract][Full Text] [Related]
14. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.
Singh D; Fox SM; Tal-Singer R; Plumb J; Bates S; Broad P; Riley JH; Celli B;
Thorax; 2011 Jun; 66(6):489-95. PubMed ID: 21441172
[TBL] [Abstract][Full Text] [Related]
15. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
16. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
[TBL] [Abstract][Full Text] [Related]
17. Sputum ADAM8 expression is increased in severe asthma and COPD.
Oreo KM; Gibson PG; Simpson JL; Wood LG; McDonald VM; Baines KJ
Clin Exp Allergy; 2014 Mar; 44(3):342-52. PubMed ID: 24147597
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
19. Increased sputum IL-8 and IL-5 in asymptomatic nonspecific airway hyperresponsiveness.
Betz R; Kohlhäufl M; Kassner G; Müllinger B; Maier K; Brand P; Weber N; Häussinger K; Heyder J; Frankenberger M
Lung; 2001; 179(2):119-33. PubMed ID: 11733854
[TBL] [Abstract][Full Text] [Related]
20. Decreased indoleamine 2,3-dioxygenase activity and IL-10/IL-17A ratio in patients with COPD.
Maneechotesuwan K; Kasetsinsombat K; Wongkajornsilp A; Barnes PJ
Thorax; 2013 Apr; 68(4):330-7. PubMed ID: 23255616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
